Press release
Brain Cancer Market Size is Set for Rapid Growth as Innovative Treatments and Rising Awareness Drive Demand by 2034
Brain Cancer Market
[Nevada, United States] - DelveInsight's "Brain Cancer Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Brain Cancer, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the Brain Cancer Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; https://www.delveinsight.com/report-store/brain-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Key Findings from the Brain Cancer Market Report:
The Brain Cancer market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2020-2034).
In August, 2024: Reveal Pharmaceuticals Inc. announced that the goal of their study is to assess safety, efficacy, and pharmacokinetics of RVP-001 at three dose levels. The study will also compare RVP-001 imaging to gadolinium-based contrast agent (GBCA) imaging.
In August, 2024: Shanghai Pharmaceuticals Holding Co., Ltd announced that their study evaluated the safety and efficacy of SPH4336 in combination with endocrine therapy in breast cancer Patients with brain metastases.
In July, 2024: GT Medical Technologies, Inc. announced that their trial will be a randomized controlled study comparing the efficacy and safety of intraoperative radiation therapy using GammaTilesTM (GT) versus SRT 3-4 weeks following metastatic tumor resection which is the current standard of care.
In May, 2024: Bristol-Myers Squibb announced that the purpose of their study is to evaluate patients with glioblastoma that is MGMT-methylated (the MGMT gene is altered by a chemical change). Patients will receive temozolomide plus radiation therapy. They will be compared to patients receiving nivolumab in addition to temozolomide plus radiation therapy.
According to DelveInsight analysis, the United States contributed to the largest incident population in 2022, accounting around 40% of the total incident cases of glioma, which is expected to increase during the forecast period.
In the 7MM, the maximum number of cases were found for Grade IV glioma, accounting for nearly33,000 cases in 2022,which is followed by Grade II and Grade III glioma.
Among the EU4 and the UK, Germany accounted for the highest number of GBM cases, followed by France, whereasItalyaccounted for the lowest cases in 2022.
Key Brain Cancer Companies are as follows: Genentech, Merck, Azurity Pharmaceuticals, Sevier, Kazia Therapeutics, Chimerix, Aivita Bio-medical, Medicenna Therapeutics
Key Brain Cancer Therapies are as follow: AVASTIN, TEMODAR/TEMODAL, GLIADEL Wafer, Vorasidenib, Paxalisib, ONC201, AV GBM 1, MDNA55.
Launching multiple stage Brain Cancer pipeline products is expected to revolutionize market dynamics, further propelling market growth.
Dive into our detailed Brain Cancer market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/sample-request/brain-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Brain Cancer Overview:
A brain tumor, known as an intracranial tumor, central nervous system (CNS) tumors represent a group of diseases thathave in common the abnormal development of mass lesions in the brain, spinal cord or its coverings. A brain tumor can beclassified into two main groups, i.e., primary and metastatic.
Brain Cancer Drugs Uptake and Pipeline Development Activities:
The drugs uptake section focuses on the rate of uptake of potential drugs recently launched or expected to be launched during the study period. The report covers market uptake by drugs, patient uptake by therapies, and sales of each drug. Additionally, it provides insights into Brain Cancer Pipeline Development Activities, analyzing therapeutic candidates in various stages and key companies involved.
For more information about Brain Cancer companies working in the treatment market, visit Brain Cancer Clinical Trials
Brain Cancer Therapies and Key Companies:
AVASTIN (bevacizumab): Genentech
TEMODAR/TEMODAL: Merck
GLIADEL Wafer: Azurity Pharmaceuticals
Vorasidenib: Servier
Paxalisib: Kazia Therapeutics
ONC201: Chimerix
AV GBM 1: Aivita Bio-medical
MDNA55: Medicenna Therapeutics
Brain Cancer Epidemiology:
The epidemiology section provides insights into historical, current, and forecasted trends in the seven major countries (7MM) from 2020 to 2034. It explores various studies and opinions to recognize the causes of current and forecasted trends. The segmentation includes total prevalence, severity-based prevalence, gender-specific prevalence, and diagnosed cases of episodic and chronic Brain Cancer.
Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/brain-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Brain Cancer Epidemiology Segmentation:
The Brain Cancer market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
Brain Cancer Total Prevalence
Brain Cancer Prevalent Cases by severity
Brain Cancer Gender-specific Prevalence
Brain Cancer Diagnosed Cases of Episodic and Chronic
Brain Cancer Market Drivers:
Rising Incidence of Brain Cancer
Advancements in Diagnostic Technologies
Development of Targeted Therapies
Increased Funding and Research Initiatives
Brain Cancer Market Barriers:
Limited Treatment Options for Aggressive Tumors
Complexity of Drug Delivery to the Brain
Adverse Side Effects of Treatment
Low Survival Rates and Poor Prognosis
Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/brain-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Scope of the Brain Cancer Market Report:
Study Period: 2020-2034
Coverage: 7MM (The United States, EU5, and Japan)
Key Brain Cancer Companies: Genentech, Merck, Azurity Pharmaceuticals, Sevier, Kazia Therapeutics, Chimerix, Aivita Bio-medical, Medicenna Therapeutics
Key Brain Cancer Therapies: AVASTIN, TEMODAR/TEMODAL, GLIADEL Wafer, Vorasidenib, Paxalisib, ONC201, AV GBM 1, MDNA55.
Brain Cancer Therapeutic Assessment: Current marketed and emerging therapies
Brain Cancer Market Dynamics: Brain Cancer Market drivers and Brain Cancer barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Brain Cancer Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.
To access the full report and gain a deeper understanding of Brain Cancer market outlook, drug uptake, treatment scenario, and epidemiology trends: https://www.delveinsight.com/sample-request/brain-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Table of Content:
1 Key Insights
2 Report Introduction
3 Executive Summary
4 Brain Cancer Market Overview at a Glance
5 Key Events
6 Epidemiology and Market Forecast Methodology
7 Disease Background and Overview
8 Treatment
9 Treatment Algorithm
10 Epidemiology and Patient Population
11 Patient Journey
12 Marketed Drugs
13 Emerging Therapies
14 Brain Cancer: Seven Major Market Analysis
15 Unmet Needs
16 SWOT Analysis
17 KOL Views
18 Reimbursement and Market Access
19 Appendix
20 DelveInsight Capabilities
21 Disclaimer
22 About DelveInsight
List of TOP Selling Inhibitors Market Research Report as of 2024:
CTLA-4 Inhibitors Market: https://www.delveinsight.com/report-store/ctla4-inhibitors-market-forecast
VEGF Inhibitors Market: https://www.delveinsight.com/report-store/vegf-inhibitors-market-forecast
TROP-2 Inhibitors Market: https://www.delveinsight.com/report-store/trop2-inhibitors-market-forecast
HER2+ Market: https://www.delveinsight.com/report-store/her2-positive-market-forecast
HER3+ Market: https://www.delveinsight.com/report-store/her3-positive-market-forecast
FTase Inhibitors Market: https://www.delveinsight.com/report-store/ftase-inhibitors-market-forecast
Bispecifics Market: https://www.delveinsight.com/report-store/bispecifics-market-forecast
CAR-T Market: https://www.delveinsight.com/report-store/car-t-market-forecast
CD-19 Market: https://www.delveinsight.com/report-store/cd19-market-forecast
CD-20 Market: https://www.delveinsight.com/report-store/cd20-market-forecast
CD-38 Market: https://www.delveinsight.com/report-store/cd38-market-forecast
TP-53 Market: https://www.delveinsight.com/report-store/tp53-market-forecast
NTRK Market: https://www.delveinsight.com/report-store/ntrk-market-forecast
BRCA Market: https://www.delveinsight.com/report-store/brca-market-forecast
SMAD4/DPC4 Market: https://www.delveinsight.com/report-store/smad4-dpc4-market-forecast
Connective Tissue Growth Factor (CTGF) Inhibitors Market: https://www.delveinsight.com/report-store/connective-tissue-growth-factor-ctgf-inhibitors-market-forecast
Selective Inhibitor of the CXCR4 Chemokine Receptor Market: https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
PI3K Market: https://www.delveinsight.com/report-store/pi3k-market-forecast
FGFR Market: https://www.delveinsight.com/report-store/fgfr-market-forecast
PROTAC Market: https://www.delveinsight.com/report-store/protac-market-forecast
CEACAM5 Market: https://www.delveinsight.com/report-store/ceacam5-market-forecast
Anti Cancer Vaccine Market: https://www.delveinsight.com/report-store/anti-cancer-vaccine-market-forecast
Androgen Receptor Inhibitor Market: https://www.delveinsight.com/report-store/androgen-receptor-inhibitor-market-forecast
GnRH Receptor Antagonist Market: https://www.delveinsight.com/report-store/gnrh-receptor-antagonist-market-forecast
CDK4/6 Inhibitor Market: https://www.delveinsight.com/report-store/cdk4-6-inhibitor-market-forecast
SERD Market: https://www.delveinsight.com/report-store/serd-market-forecast
AKT Inhibitor Market: https://www.delveinsight.com/report-store/akt-inhibitor-market-forecast
Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
B7-H3 Market: https://www.delveinsight.com/report-store/b7-h3-market-forecast
CYP17 Inhibitor Market: https://www.delveinsight.com/report-store/cyp17-inhibitor-market-forecast
NTD AR Inhibitor Market: https://www.delveinsight.com/report-store/ntd-ar-inhibitor-market-forecast
NRG fusion Market: https://www.delveinsight.com/report-store/nrg-fusion-market-forecast
AXL Receptor Tyrosine Kinase Inhibitors Market: https://www.delveinsight.com/report-store/axl-receptor-tyrosine-kinase-inhibitors-market-forecast
PSMA-Targeted Therapy Market: https://www.delveinsight.com/report-store/psma-targeted-therapy-market-forecast
EGFR Market: https://www.delveinsight.com/report-store/egfr-market-forecast
ALK Market: https://www.delveinsight.com/report-store/alk-market-forecast
BRAF Market: https://www.delveinsight.com/report-store/braf-market-forecast
ERBB 2 Receptor Antagonists Market: https://www.delveinsight.com/report-store/erbb2-receptor-antagonists-market-forecast
VEGFR-2 Inhibitor Market: https://www.delveinsight.com/report-store/vegfr2-inhibitor-market-forecast
Thymidine Phosphorylase Inhibitors Market: https://www.delveinsight.com/report-store/thymidine-phosphorylase-inhibitors-market-forecast
DNA Synthesis Inhibitor Market: https://www.delveinsight.com/report-store/dna-synthesis-inhibitor-market-forecast
CD223 Antigen Inhibitors Market: https://www.delveinsight.com/report-store/cd223-antigen-inhibitors-market-forecast
BTK Inhibitors Market: https://www.delveinsight.com/report-store/btk-inhibitors-market-forecast
SERMS Market: https://www.delveinsight.com/report-store/serms-market-forecast
PLK1 Inhibitor Market: https://www.delveinsight.com/report-store/plk1-inhibitor-market-forecast
CD47 Antigen Inhibitors Market: https://www.delveinsight.com/report-store/cd47-antigen-inhibitors-market-forecast
RET Fusion Market: https://www.delveinsight.com/report-store/ret-fusion-market-forecast
ROS-1 Market: https://www.delveinsight.com/report-store/ros1-market-forecast
Mesenchymal-epithelial Transition Factor (MET) Market: https://www.delveinsight.com/report-store/mesenchymal-epithelial-transition-factor-met-market-forecast
MET Kinase Inhibitor Market: https://www.delveinsight.com/report-store/met-kinase-inhibitor-market-forecast
About DelveInsight:
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.
Contact Information:
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Brain Cancer Market Size is Set for Rapid Growth as Innovative Treatments and Rising Awareness Drive Demand by 2034 here
News-ID: 3655383 • Views: …
More Releases from DelveInsight Business Research LLP
Oral Mucositis Pipeline Insights, Treatment Drugs, Clinical Trials, and Companie …
(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ Oral Mucositis companies continuously working towards developing 10+ Oral Mucositis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
To explore more information on the latest breakthroughs in the Oral Mucositis Pipeline treatment landscape of the report, click here @ Oral Mucositis Pipeline Outlook- https://www.delveinsight.com/report-store/oral-mucositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the…
Alpha-1 Antitrypsin Deficiency Pipeline Insight, Treatment Drugs, Clinical Trial …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers the Alpha-1 Antitrypsin Deficiency pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alpha-1 Antitrypsin Deficiency pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample…
Constipation Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies …
DelveInsight's, "Constipation Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers the Constipation pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Constipation pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances in…
Cirrhosis Pipeline Insights, Clinical Trials, Treatment Drugs, and Companies 202 …
DelveInsight's, "Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances in Cirrhosis Treatment…
More Releases for Market:
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned?
In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth…
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects.
The International Technology Roadmap for Semiconductors (ITRS) has emphasized…
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by…
Global Organic Food & Beverage Market | Market Size, Market Share, Market Trends …
The term 'organic' has gained much popularity since the last decade, which refers to the process of how certain foods are produced. Organic food is grown without the use of synthetic chemicals, such as human-made pesticides and fertilizers, and does not contain genetically modified organisms (GMOs). According to the recently published report titled, 'Global Organic Food & Beverage Outlook, 2026', by Bonafide Research the organic foods & beverage industry has…
Robotic Cardiology Surgery Market Insights Includes Market Share, Market Researc …
Robotic Cardiology Surgery Market
Global demand for cardiac surgery robots in 2025 will explode to $XXX billion. This represents an astonishing XX% growth yearly in terms of annual revenue between 2016 and 2025, and a cumulative market total of $7.50 billion during 2017-2025 owing to the substantial increase of robot-based and computer-assisted cardiological surgery procedures for heart disorders.
Global Robotic Cardiology Surgery Market 2016-2025: Market Size, Share, Forecast and Strategy is based…
Educational Robots Market, Market Segmentation, Market Report, Market Forecast
Global Educational Robots market valued USD 670 Million in 2017 and is likely to grow more than USD 2339.8 Million by 2025 with a compounded annual growth of 16.92% over the forecast period 2018-2025. The market growth is primarily driven by technological enhancements in the field of robotics and increasing use of robots for educational purposes. However, high initial research and development expenses hamper market growth. The main function of…
